Allogene Therapeutics Inc (ALLO)
2.96
+0.04
(+1.54%)
USD |
NASDAQ |
May 02, 16:00
2.96
0.00 (0.00%)
After-Hours: 20:00
Allogene Therapeutics Total Long Term Debt (Quarterly): 0.00 for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
Date | Value |
---|---|
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2021
--
Maximum
Mar 2021
--
Average
--
Median
Mar 2021
Total Long Term Debt (Quarterly) Benchmarks
Agenus Inc | 12.91M |
ANI Pharmaceuticals Inc | 285.67M |
Vaxart Inc | 0.00 |
aTyr Pharma Inc | -- |
PAVmed Inc | 44.20M |